Metabolic syndrome and stroke: A meta-analysis of prospective cohort studies

Journal of Clinical Neuroscience

Volumn 40, Issue , 2017, Pages 34-38

  Li, Xuelong ^a   Li, Xianliang ^a   Lin, Hualiang ^b   Fu, Xian ^a   Lin, Wanrong ^a   Li, Mingkun ^a   Zeng, Xianfan ^a   Gao, Qingchun ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Incident; Meta analysis; Metabolic syndrome; Stroke

Indexed keywords

BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; HIGH RISK POPULATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INCIDENCE; METABOLIC SYNDROME X; OBESITY; PREDICTION; REVIEW; RISK FACTOR; SEX DIFFERENCE; SYSTEMATIC REVIEW; COMPLICATION; FEMALE; MALE; META ANALYSIS;

FEMALE; HUMANS; MALE; METABOLIC SYNDROME; STROKE;

EID: 85014157317     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2017.01.018     Document Type: Review

References (38)

1. [1] Alberti, K.G., Eckel, R.H., Grundy, S.M., et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 120 (2009), 1640–1645.
2. [2] Ford, E.S.G.W., Dietz, W.H., Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. JAMA 287 (2002), 356–359.
3. [3] Xi, B., He, D., Hu, Y., et al. Prevalence of metabolic syndrome and its influencing factors among the chinese adults: the china health and nutrition survey in 2009. Prev Med 57 (2013), 867–871.
4. [4] Reaven, G.M., Banting lecture 1988 role of insulin resistance in human disease. Diabetes 37 (1988), 1595–1607.
5. [5] Alberti KG1, ZP, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation, 15, 1998, Diabet Med, 539–553.
6. [6] National Cholesterol Education Program. (NCEP) Expert panel on detection E, and treatment of high blood cholesterol in adults (adult treatment panel III. Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 106 (2002), 3143–3421.
7. [7] Alberti, K.G.Z.P., Shaw, J., Metabolic syndrome–a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med 23 (2006), 469–480.
8. [8] Grundy, S.M., Brewer, H.B. Jr., Cleeman, J.I., et al. Definition of metabolic syndrome: report of the national heart, lung, and blood institute/american heart association conference on scientific issues related to definition. Circulation 109 (2004), 433–438.
9. [9] Expert panel on detection e, and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285 (2001), 2486–2497.
10. [10] Garg, P.K., Biggs, M.L., Carnethon, M., et al. Metabolic syndrome and risk of incident peripheral artery disease: the cardiovascular health study. Hypertension 63 (2014), 413–419.
11. [11] Mottillo, S., Filion, K.B., Genest, J., et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 56 (2010), 1113–1132.
12. [12] Kahn, R.B.J., Ferrannini, E., Stern, M., et al. American diabetes association; european association for the study of diabetes. The metabolic syndrome: time for a critical appraisal: joint statement from the american diabetes association and the european association for the study of diabetes. Diabetes Care 28 (2005), 2289–2304.
13. [13] McNeill, A.M.R.W., Girman, C.J., Golden, S.H., The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 28 (2005), 385–390.
14. [14] Sone, H.M.S., Fujii, H., Yoshimura, Y., Japan diabetes complications study. Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in asian diabetic patients? Analysis from the Japan diabetes complications study. Diabetes Care 28 (2005), 1463–1471.
15. [15] Chei, C.L.Y.K., Tanigawa, T., Kitamura, A., et al. Metabolic syndrome and the risk of ischemic heart disease and stroke among middle-aged japanese. Hypertens Res 31 (2008), 1887–1894.
16. [16] Boden-Albala, B., Sacco, R.L., Lee, H.S., et al. Metabolic syndrome and ischemic stroke risk: northern manhattan study. Stroke 39 (2008), 30–35.
17. [17] Chien, K.L., Hsu, H.C., Sung, F.C., et al. Metabolic syndrome as a risk factor for coronary heart disease and stroke: an 11-year prospective cohort in Taiwan community. Atherosclerosis 194 (2007), 214–221.
18. [18] Iso, H., Sato, S., Kitamura, A., et al. Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women. Stroke 38 (2007), 1744–1751.
19. [19] Jia, Z., Wu, S., Zhou, Y., et al. Metabolic syndrome and its components as predictors of stroke in middle-aged and elderly Chinese people. Neurol Res 33 (2011), 453–459.
20. [20] Kurl, S., Laukkanen, J.A., Niskanen, L., et al. Metabolic syndrome and the risk of stroke in middle-aged men. Stroke 37 (2006), 806–811.
21. [21] Liu, J., Grundy, S.M., Wang, W., et al. Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome. Am Heart J 153 (2007), 552–558.
22. [22] Ninomiya, T., Kubo, M., Doi, Y., et al. Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population: the Hisayama study. Stroke 38 (2007), 2063–2069.
23. [23] Rodriguez-Colon, S.M., Mo, J., Duan, Y., et al. Metabolic syndrome clusters and the risk of incident stroke: the atherosclerosis risk in communities (ARIC) study. Stroke 40 (2009), 200–205.
24. [24] Schillaci, G., Pirro, M., Vaudo, G., et al. Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol 43 (2004), 1817–1822.
25. [25] Wannamethee, S.G.S.A., Lennon, L., Morris, R.W., Metabolic syndrome vs framingham risk score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 165 (1998), 2644–2650.
26. [26] Yun, J.E., Won, S., Sung, J., et al. Impact of metabolic syndrome independent of insulin resistance on the development of cardiovascular disease. Circ J 76 (2012), 2443–2448.
27. [27] Zhang, W.W., Liu, C.Y., Wang, Y.J., et al. Metabolic syndrome increases the risk of stroke: a 5-year follow-up study in a Chinese population. J Neurol 256 (2009), 1493–1499.
28. [28] Kazlauskiene, L., Butnoriene, J., Norkus, A., Metabolic syndrome related to cardiovascular events in a 10-year prospective study. Diabetol Metab Syndr, 7, 2015, 102.
29. [29] Qiao, Q., Laatikainen, T., Zethelius, B., et al. Comparison of definitions of metabolic syndrome in relation to the risk of developing stroke and coronary heart disease in Finnish and Swedish cohorts. Stroke 40 (2009), 337–343.
30. [30] Vinluan, C.M., Zreikat, H.H., Levy, J.R., et al. Comparison of different metabolic syndrome definitions and risks of incident cardiovascular events in the elderly. Metab Clin Exp 61 (2012), 302–309.
31. [31] Wen, J., Yang, J., Shi, Y., et al. Comparisons of different metabolic syndrome definitions and associations with coronary heart disease, stroke, and peripheral arterial disease in a rural Chinese population. PLoS One, 10, 2015, e0126832.
32. [32] Li, W., Ma, D., Liu, M., et al. Association between metabolic syndrome and risk of stroke: a meta-analysis of cohort studies. Cerebrovasc Dis 25 (2008), 539–547.
33. [33] Chen, H.J., Bai, C.H., Yeh, W.T., et al. Influence of metabolic syndrome and general obesity on the risk of ischemic stroke. Stroke 37 (2006), 1060–1064.
34. [34] Dekker, J.M., Girman, C., Rhodes, T., et al. Metabolic syndrome and 10-year cardiovascular disease risk in the hoorn study. Circulation 112 (2005), 666–673.
35. [35] Ninomiya, High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study. HAMKKYYDT Arterioscler Thromb Vasc Biol 28 (2008), 1385–1391.
36. [36] Hosaka, Home blood pressure variability as cardiovascular risk factor in the population of ohasama. KAMKRSLTM Hypertension 61 (2012), 61–69.
37. [37] Niwa, Y., Ishikawa, S., Gotoh, T., et al. Association between stroke and metabolic syndrome in a japanese population: jichi medical school (JMS) cohort study. J Epidemiol 20 (2010), 62–69.
38. [38] Park, Y.K.Y.H., Lee, Y.J., Cho, H., et al. The relationship between metabolic syndrome (MetS) and spontaneous intracerebral hemorrhage (ICH). Neurol Sci 34 (2013), 1523–1528.